ArticleFrontiers in physiology2024
Association between moderate-to-vigorous physical activity and chronic disease risk in adults and elderly: insights from the UK Biobank study.
Article in Frontiers in physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A Head-to-Head Comparison of Three Literature Algorithms for Physical Activity Endpoints from a Wrist Accelerometer in Free-Living Conditions.Sensors (Basel, Switzerland) · 2026Article
- Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review.Clinical interventions in aging · 2026Review
- Isotemporal substitution of sedentary time with physical activity for cardiovascular health in older adults: a systematic review.Frontiers in sports and active living · 2026Review
- Cross-sectional analysis of the association between physical activity and metabolic syndrome in the elderly.Frontiers in endocrinology · 2026Article
- Interplay between balance, gait kinematic and physical activity level in facioscapulohumeral muscular dystrophy.Scientific reports · 2025Article
- Nationwide evidence from China on the dose-response between environmental fitness support and physical activity.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to determine the associations between different intensities of moderate to vigorous physical activity (MVPA) and the incidence of chronic diseases, and to assess the risk levels associated with these activities over time. Methods: A prospective cohort study (UK Biobank Activity Project) with data collected between June 2013 and December 2015 included 59,896 adults (mean age = 59.68; male = 38.03%) free from chronic diseases. Participants were categorized into tertiles based on their weekly MVPA: lowest (<224 min for males, <143 min for females), medium (224-444 min for males, 143-308 min for females), and highest (≥444 min for males, ≥308 min for females), stratified by gender. The mean onset of chronic disease symptoms occurred at 3.57 years, with participants followed up during this period. Wearable accelerometry data were used to quantify MVPA levels. Findings: Lowest tertile of MVPA were significantly correlated with increased risks of chronic disease (24%-110% increased risk) based on odds ratios (ORs), with dose-response relationship observed. In males with the lowest tertile of MVPA, significant associations were identified with type 2 diabetes mellitus (T2DM) (OR = 1.90; CI: 1.44-2.51), neurodegenerative disease (OR = 1.80; CI: 1.19-2.71), metabolic syndrome (OR = 1.34; CI: 1.18-1.53), hypertension (OR = 1.27; CI: 1.12-1.44), and atherosclerotic cardiovascular disease (ASCVD) (OR = 1.24; CI: 1.03-1.49). In females, the lowest tertile of MVPA levels were associated with increased risks of neurodegenerative disease (OR = 2.10; CI: 1.36-3.24), T2DM (OR = 1.88; CI: 1.37-2.58), cerebrovascular disease (OR = 1.61; CI: 1.12-2.29), ASCVD (OR = 1.58; CI: 1.23-2.03), metabolic syndrome (OR = 1.49; CI: 1.32-1.69), and hypertension (OR = 1.44; CI: 1.29-1.61). Longitudinally, the lowest tertile of MVPA in males showed elevated risks for neurodegenerative disease (HR = 2.13; CI: 1.24-3.66), T2DM (HR = 1.83; CI: 1.30-2.57), hypertension (HR = 1.33; CI: 1.15-1.53), metabolic syndrome (HR = 1.32; CI: 1.14-1.54), and ASCVD (HR = 1.29; CI: 1.03-1.61). In females, the lowest tertile of MVPA was associated with similar risks for ASCVD (HR = 1.59; CI: 1.16-2.20), T2DM (HR = 1.57; CI: 1.08-2.29), hypertension (HR = 1.53; CI: 1.34-1.74), and metabolic syndrome (HR = 1.50; CI: 1.29-1.73). Conclusion: Using wearable accelerometry data, this study demonstrated the quantifiable risks of chronic diseases and their development, highlighting the importance of MVPA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.